268 related articles for article (PubMed ID: 26402014)
1. Genetic Variation in δ-Opioid Receptor Associates with Increased β- and γ-Secretase Activity in the Late Stages of Alzheimer's Disease.
Sarajärvi T; Marttinen M; Natunen T; Kauppinen T; Mäkinen P; Helisalmi S; Laitinen M; Rauramaa T; Leinonen V; Petäjä-Repo U; Soininen H; Haapasalo A; Hiltunen M
J Alzheimers Dis; 2015; 48(2):507-16. PubMed ID: 26402014
[TBL] [Abstract][Full Text] [Related]
2. A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis.
Teng L; Zhao J; Wang F; Ma L; Pei G
Cell Res; 2010 Feb; 20(2):138-53. PubMed ID: 20066010
[TBL] [Abstract][Full Text] [Related]
3. Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking.
Sarajärvi T; Tuusa JT; Haapasalo A; Lackman JJ; Sormunen R; Helisalmi S; Roehr JT; Parrado AR; Mäkinen P; Bertram L; Soininen H; Tanzi RE; Petäjä-Repo UE; Hiltunen M
Mol Cell Biol; 2011 Jun; 31(11):2326-40. PubMed ID: 21464208
[TBL] [Abstract][Full Text] [Related]
4. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
5. SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1.
Kurkinen KM; Marttinen M; Turner L; Natunen T; Mäkinen P; Haapalinna F; Sarajärvi T; Gabbouj S; Kurki M; Paananen J; Koivisto AM; Rauramaa T; Leinonen V; Tanila H; Soininen H; Lucas FR; Haapasalo A; Hiltunen M
J Cell Sci; 2016 Jun; 129(11):2224-38. PubMed ID: 27084579
[TBL] [Abstract][Full Text] [Related]
6. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
7. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
Tomita T
Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease.
Al-Atrache Z; Lopez DB; Hingley ST; Appelt DM
BMC Neurosci; 2019 Feb; 20(1):6. PubMed ID: 30786875
[TBL] [Abstract][Full Text] [Related]
9. Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease.
Jo DG; Arumugam TV; Woo HN; Park JS; Tang SC; Mughal M; Hyun DH; Park JH; Choi YH; Gwon AR; Camandola S; Cheng A; Cai H; Song W; Markesbery WR; Mattson MP
Neurobiol Aging; 2010 Jun; 31(6):917-25. PubMed ID: 18687504
[TBL] [Abstract][Full Text] [Related]
10. γ-secretase binding sites in aged and Alzheimer's disease human cerebrum: the choroid plexus as a putative origin of CSF Aβ.
Liu F; Xue ZQ; Deng SH; Kun X; Luo XG; Patrylo PR; Rose GM; Cai H; Struble RG; Cai Y; Yan XX
Eur J Neurosci; 2013 May; 37(10):1714-25. PubMed ID: 23432732
[TBL] [Abstract][Full Text] [Related]
11. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
[TBL] [Abstract][Full Text] [Related]
12. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
[TBL] [Abstract][Full Text] [Related]
13. β-amyloid 1-42 induces physiological transcriptional regulation of BACE1.
Piccini A; Borghi R; Guglielmotto M; Tamagno E; Cirmena G; Garuti A; Pollero V; Cammarata S; Fornaro M; Messa M; Colombo L; Salmona M; Perry G; Tabaton M
J Neurochem; 2012 Sep; 122(5):1023-31. PubMed ID: 22708832
[TBL] [Abstract][Full Text] [Related]
14. Carnosic acid suppresses the production of amyloid-β 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells.
Meng P; Yoshida H; Matsumiya T; Imaizumi T; Tanji K; Xing F; Hayakari R; Dempoya J; Tatsuta T; Aizawa-Yashiro T; Mimura J; Kosaka K; Itoh K; Satoh K
Neurosci Res; 2013 Feb; 75(2):94-102. PubMed ID: 23257508
[TBL] [Abstract][Full Text] [Related]
15. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
Tang K; Hynan LS; Baskin F; Rosenberg RN
J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
[TBL] [Abstract][Full Text] [Related]
16. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.
Faghihi MA; Modarresi F; Khalil AM; Wood DE; Sahagan BG; Morgan TE; Finch CE; St Laurent G; Kenny PJ; Wahlestedt C
Nat Med; 2008 Jul; 14(7):723-30. PubMed ID: 18587408
[TBL] [Abstract][Full Text] [Related]
17. Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage.
Whitehouse IJ; Miners JS; Glennon EB; Kehoe PG; Love S; Kellett KA; Hooper NM
PLoS One; 2013; 8(4):e59554. PubMed ID: 23577068
[TBL] [Abstract][Full Text] [Related]
18. The molecular link between beta- and gamma-secretase activity on the amyloid beta precursor protein.
Tabaton M; Tamagno E
Cell Mol Life Sci; 2007 Sep; 64(17):2211-8. PubMed ID: 17604999
[TBL] [Abstract][Full Text] [Related]
19. Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.
Carson R; McKnight AJ; Todd S; Liu WW; Heggarty S; Craig D; McGuinness B; Irvine GB; Passmore AP; Johnston JA
Neuromolecular Med; 2009; 11(4):337-44. PubMed ID: 19669607
[TBL] [Abstract][Full Text] [Related]
20. Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.
Maiorini AF; Gaunt MJ; Jacobsen TM; McKay AE; Waldman LD; Raffa RB
J Clin Pharm Ther; 2002 Jun; 27(3):169-83. PubMed ID: 12081630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
